Brain fog and CBD: what the science allows us to say
Brain fog is not a diagnosis. The phrase is the everyday name for a complaint that combines slowed thinking, lack of clarity and trouble paying attention. France's health authority (HAS) describes it in long Covid in particular, and lack of sleep is a well-documented cause. We found no study showing that CBD improves concentration in healthy adults, and a 2025 trial at 246 mg found no effect on memory.
Key takeaways
- "Brain fog" names a feeling, and no disease matches it; finding the cause is a doctor's job.
- On weekdays in 2017, French adults slept 6 h 42 per 24 hours on average, under the recommended minimum of 7 hours.
- In a 2025 crossover trial, 246 mg of CBD had no measurable effect on learning or memory in 35 adults.
- Anxiety trials give 150 to 600 mg in a single dose, 75 to 300 times EFSA's provisional level.
- In France, no CBD product may claim an effect on concentration.
A complaint, not a diagnosis
The expression "brain fog" corresponds to no defined disease. The medical literature uses it in very different settings: long Covid, disorders of wakefulness, and hypothyroidism, examined in a review published in 2022 in Thyroid.
The Haute Autorité de santé describes it precisely in its sheet on the neurological symptoms of long Covid, updated in March 2022. Patients report mental slowing, unclear thinking, trouble paying attention and words that will not come. The sheet recommends a first assessment with a standardised test, the MoCA, and a neurological opinion if the problem persists.
This starting point shapes what follows: a word covering several causes has no single remedy, and no product can claim to clear it.
Sleep, the first cause to look at
In its sleep file, Inserm, the French medical research institute, notes that sleep contributes to concentration, learning and memory. The Santé publique France survey it cites found that in 2017 adults slept 6 h 42 per 24 hours on average on weekdays, under the 7 hours usually recommended as a minimum. Over the whole week, the average was 6 h 55.
Regular lack of sleep can be enough on its own to produce some of the symptoms grouped under this name. Other possible causes, such as a thyroid problem, a side effect of a medicine or the aftermath of an infection, call for a medical examination. If the problem lasts several weeks or comes with other signs, talk to your doctor.
What trials say about CBD and cognition
Studies are few and often small, and none of them enrolled people complaining of brain fog.
| Study | Participants | Dose | Result |
|---|---|---|---|
| Crossover trial, 2025 | 35 healthy adults analysed | 246 mg, by mouth | No effect on learning and verbal memory |
| Driving trial, 2020 | 26 occasional cannabis users | 13.75 mg vaporised | No difference from placebo, unlike THC |
| Public speaking, 2019 | 57 healthy men | 150, 300 or 600 mg | Lower reported anxiety at 300 mg only |
| Case series, 2019 | 72 adults seen at a psychiatric clinic | Variable | Anxiety scores down in 79.2%, no control group |
Published in the Journal of Cannabis Research, the 2025 trial set out to check that CBD does not impair memory. It found no difference from placebo in either direction. The driving trial published in JAMA in 2020 points the same way in another setting: CBD-rich cannabis left lane keeping unchanged, while THC-rich cannabis made it worse.
The 2019 public speaking trial is often cited for anxiety, and its bell-shaped curve deserves attention. Reported anxiety fell at 300 mg, while 150 and 600 mg made no difference compared with placebo. Our article on CBD's biphasic effect examines this pattern. The 2019 case series had no control group, so it cannot separate the product's effect from natural change or the placebo effect.
A 2021 systematic review of brain imaging pools 17 studies and concludes that CBD alters the activity of certain brain networks. A change on an MRI scan is a different thing from better performance, and none of these studies measures a gain in everyday concentration.
Trial doses bear no relation to a shop product
The memory and anxiety trials give single doses of 150 to 600 mg. EFSA set on 9 February 2026 a provisional safe intake of 0.0275 mg per kilo per day for food supplements based on pure CBD. For a 70 kg adult, that comes to about 2 mg.
The gap ranges from 75-fold to 300-fold, so a result obtained at 300 mg says nothing about the effect of a drop of oil. Our article on EFSA's reference dose explains the calculation, and the one on CBD and concentration covers what a shop may and may not say.
French rules
The French drug policy agency MILDECA reminds sellers that no CBD product may claim a therapeutic effect in France. Foods and food supplements containing CBD are not authorised, as the French Ministry of Agriculture's notice of 20 May 2026 restates. EFSA adds that the safety of CBD has not been established under the age of 25, during pregnancy or breastfeeding, or for people on medication.
Liver enzymes that also handle many medicines break CBD down. If you take any treatment, a sleeping pill or an anti-anxiety drug in particular, talk to your doctor. Our article on CBD and the liver describes this mechanism, and the one on CBD and sleep reviews the trials on sleep.
Frequently asked questions
No. The phrase is the everyday name for a complaint combining slowed thinking, lack of clarity and trouble paying attention. Lack of sleep, a thyroid problem, long Covid or a side effect of medication can all be behind it. If it persists, a doctor can sort out the cause.
We found no good-quality study showing it in healthy adults. In a 2025 trial in 35 adults, 246 mg of CBD had no effect on learning or memory.
The available trials do not show it: neither the 2025 memory trial nor the driving trial published in JAMA in 2020 found a difference from placebo. Drowsiness does appear among the side effects recorded at very high doses, from 750 to 6,000 mg, in a phase I trial published in 2018. A product with too much THC can also lower alertness.
These trials look for an effect that can be measured after a single dose in volunteers. Their doses of 150 to 600 mg are 75 to 300 times EFSA's provisional level of 2 mg per day for a 70 kg adult.
Written by the Phytogrammes team
Each journal article draws on cited primary sources: ANSM, EFSA, EUR-Lex and peer-reviewed publications. Product profiles are distinguished from documented laboratory results. Our approach.
Article published on . CBD is not a medicine.